Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
GMDA
Gamida Cell Ltd.
14
Follow
14
GMDA
Gamida Cell Ltd.
14
Follow
14
Likes Subject
Older
Newer
Gamida Cell Announces FDA Acceptance of Biologics License midastouch017 08/01/22 7:44 AM
2.3500+0.1800 (+8.29%) midastouch017 08/09/22 12:05 PM
These 2 Penny Stocks Are Poised for a midastouch017 08/09/22 11:12 AM
Gamida Cell Announces the Date of Its Second midastouch017 08/08/22 8:15 AM
Yes, I thought so as well. I guess we murocman 08/01/22 10:15 AM
Good news midastouch017 08/01/22 7:53 AM
Gamida stock rises 13% as FDA grants priority midastouch017 08/01/22 7:51 AM
Gamida Cell Announces FDA Acceptance of Biologics License midastouch017 08/01/22 7:44 AM
Yeah I read it and it seems like murocman 08/01/22 7:35 AM
Read this: midastouch017 08/01/22 4:45 AM
I always get BLA’s and NDA’s mixed up. murocman 07/31/22 4:27 PM
The FDA has 60 days to determine whether midastouch017 07/31/22 1:27 PM
Gamida Cell (GMDA) Investor Presentation- Slideshow midastouch017 06/25/22 7:24 AM
Gamida Cell Ltd.'s (NASDAQ:GMDA) Shift From Loss To Profit midastouch017 06/25/22 7:22 AM
Gamida Cell to Present Corporate Highlights at the midastouch017 06/13/22 7:42 AM
The Company also announces the resignation of Ofer midastouch017 06/10/22 7:52 AM
Gamida Cell Appoints Ivan M. Borrello, M.D., Expert midastouch017 06/10/22 7:51 AM
Gamida Cell to Present Corporate Highlights at the midastouch017 06/02/22 8:52 AM
Omidubicel, if approved, has the potential to improve midastouch017 06/02/22 8:49 AM
Gamida Cell Completes Rolling Biologics License Application Submission midastouch017 06/02/22 8:37 AM
Gamida Cell Announces Opening to Enrollment of Company-Sponsored midastouch017 06/01/22 8:00 AM
Gamida Cell to Present Corporate Highlights at the midastouch017 05/18/22 12:46 AM
Gamida Cell Ltd. (GMDA) Management on Q1 2022 midastouch017 05/10/22 12:12 PM
Gamida Cell GAAP EPS of -$0.34 in-line midastouch017 05/10/22 8:32 AM
Gamida Cell Reports First Quarter 2022 Financial Results midastouch017 05/10/22 8:24 AM
Gamida Cell Presents New Data from NAM-Enabled Genetically midastouch017 05/05/22 8:34 AM
Gamida Cell Announces the Date of Its First midastouch017 05/03/22 8:27 AM
Gamida Cell stock falls a day after soaring midastouch017 04/27/22 1:35 PM
Today's premarket activity indicates shorts midastouch017 04/27/22 8:50 AM
Gamida Cell Presents Updated One-Year Post-Transplant Follow Up midastouch017 04/27/22 8:18 AM
Alliance Global Partners Thinks Gamida Cell’s Stock is midastouch017 04/27/22 4:51 AM
BIOS ended even worse: midastouch017 04/27/22 12:27 AM
Market Summary midastouch017 04/26/22 3:28 PM
How about DOWN 7%. Pedro is right......the stockpicker7 04/26/22 3:03 PM
GDA-201 is good news, however 'Omidubicel midastouch017 04/26/22 8:41 AM
It's getting to the point where we cannot Pedro2004 04/26/22 8:33 AM
Gamida Cell Announces FDA Clearance of IND and midastouch017 04/26/22 8:31 AM
Gamida Cell Presents Updated Omidubicel Data During Best midastouch017 04/26/22 4:28 AM
Gamida Cell Announces Results of New Health Economic midastouch017 04/25/22 10:40 AM
https://stocktwits.com/dup007/message/451920034 midastouch017 04/13/22 4:23 AM
Gamida Cell to Present Corporate Highlights and Participate midastouch017 04/07/22 8:17 AM
Gamida Cell Ltd. (NASDAQ:GMDA) midastouch017 03/29/22 11:26 AM
Annual Report (10-k) midastouch017 03/24/22 9:48 AM
Spire Wealth Management Buys Shares of 55,125 Gamida midastouch017 03/23/22 3:15 PM
Gamida Cell Ltd. (NASDAQ:GMDA) Given Consensus Rating of midastouch017 03/23/22 9:29 AM
Gamida Cell Ltd. (GMDA) Q4 2021 Earnings Call Transcript midastouch017 03/15/22 1:17 PM
Gamida Cell Reports Fourth Quarter and Full Year midastouch017 03/15/22 9:00 AM
Gamida Cell to Present Corporate Highlights at the midastouch017 03/11/22 12:45 AM
Gamida Cell Announces the Date of Its Fourth midastouch017 03/08/22 8:27 AM
3.6900+0.3300 (+9.8214%) midastouch017 03/01/22 12:38 PM
Gamida Cell surges 22% following rolling BLA submission midastouch017 02/10/22 5:39 AM
Likes Subject
Older
Newer

Older
Newer
midastouch017
08/01/22 7:44 AM
midastouch017
08/09/22 12:05 PM
midastouch017
08/09/22 11:12 AM
midastouch017
08/08/22 8:15 AM
murocman
08/01/22 10:15 AM
midastouch017
08/01/22 7:53 AM
midastouch017
08/01/22 7:51 AM
midastouch017
08/01/22 7:44 AM
murocman
08/01/22 7:35 AM
midastouch017
08/01/22 4:45 AM
murocman
07/31/22 4:27 PM
midastouch017
07/31/22 1:27 PM
midastouch017
06/25/22 7:24 AM
midastouch017
06/25/22 7:22 AM
midastouch017
06/13/22 7:42 AM
midastouch017
06/10/22 7:52 AM
midastouch017
06/10/22 7:51 AM
midastouch017
06/02/22 8:52 AM
midastouch017
06/02/22 8:49 AM
midastouch017
06/02/22 8:37 AM
midastouch017
06/01/22 8:00 AM
midastouch017
05/18/22 12:46 AM
midastouch017
05/10/22 12:12 PM
midastouch017
05/10/22 8:32 AM
midastouch017
05/10/22 8:24 AM
midastouch017
05/05/22 8:34 AM
midastouch017
05/03/22 8:27 AM
midastouch017
04/27/22 1:35 PM
midastouch017
04/27/22 8:50 AM
midastouch017
04/27/22 8:18 AM
midastouch017
04/27/22 4:51 AM
midastouch017
04/27/22 12:27 AM
midastouch017
04/26/22 3:28 PM
stockpicker7
04/26/22 3:03 PM
midastouch017
04/26/22 8:41 AM
Pedro2004
04/26/22 8:33 AM
midastouch017
04/26/22 8:31 AM
midastouch017
04/26/22 4:28 AM
midastouch017
04/25/22 10:40 AM
midastouch017
04/13/22 4:23 AM
midastouch017
04/07/22 8:17 AM
midastouch017
03/29/22 11:26 AM
midastouch017
03/24/22 9:48 AM
midastouch017
03/23/22 3:15 PM
midastouch017
03/23/22 9:29 AM
midastouch017
03/15/22 1:17 PM
midastouch017
03/15/22 9:00 AM
midastouch017
03/11/22 12:45 AM
midastouch017
03/08/22 8:27 AM
midastouch017
03/01/22 12:38 PM
midastouch017
02/10/22 5:39 AM

Gamida Cell Ltd. (GMDA)

Followers
14
Posters
20
Posts (Today)
6
Posts (Total)
497
Created
05/09/19
Type
Free
Moderators midastouch017

 
Gamida Cell Ltd., a clinical stage biopharmaceutical company, focuses on developing cell therapies to cure cancer, and rare and serious hematologic diseases. The company's lead product candidate is NiCord, a nicotinamide (NAM)-expanded cord blood cell therapy that is in Phase III studies in patients with high-risk hematologic malignancies, as well as in Phase I/II studies in patients with severe aplastic anemia. It is also developing NAM-NK, an innate immunotherapy, which is in Phase I studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was founded in 1998 and is headquartered in Jerusalem, Israel.
 

Gamida Cell Ltd.




 

Most Liked Posts
(Last 30 Days)
rwwine 03/24/23 5:05 AM
1
Will be adding today below $1.30. I consider
Volume:
Day Range:
Last Trade Time:
Upgrade to Real-Time
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Detailed Quote
GMDA Latest News
More GMDA News
Most Liked Posts
(Last 30 Days)
rwwine
03/24/23 5:05 AM
1
View More
New Post